Simulations Plus (NASDAQ: SLP) and Cotiviti Holdings (NASDAQ:COTV) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends.
Insider & Institutional Ownership
32.2% of Simulations Plus shares are held by institutional investors. 36.9% of Simulations Plus shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This is a breakdown of recent ratings and recommmendations for Simulations Plus and Cotiviti Holdings, as reported by MarketBeat.com.
||Strong Buy Ratings
Cotiviti Holdings has a consensus price target of $41.20, suggesting a potential upside of 15.70%. Given Cotiviti Holdings’ higher possible upside, analysts clearly believe Cotiviti Holdings is more favorable than Simulations Plus.
Valuation and Earnings
This table compares Simulations Plus and Cotiviti Holdings’ revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
Cotiviti Holdings has higher revenue and earnings than Simulations Plus.
This table compares Simulations Plus and Cotiviti Holdings’ net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Simulations Plus pays an annual dividend of $0.20 per share and has a dividend yield of 1.2%. Cotiviti Holdings does not pay a dividend. Simulations Plus pays out 62.5% of its earnings in the form of a dividend.
Simulations Plus beats Cotiviti Holdings on 8 of the 13 factors compared between the two stocks.
Simulations Plus Company Profile
Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.
Cotiviti Holdings Company Profile
Cotiviti Holdings, Inc. is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States. The Company also provides analytics-based solutions unrelated to its healthcare payment accuracy solutions in the United States. Through its Global Retail and Other segment, the Company provides retrospective claims accuracy solutions to retailers primarily in the United States, Canada and the United Kingdom, as well as solutions that manage payment networks for a range of clients. The Company leverages its technology platform, configurable analytics, information assets and expertise in healthcare reimbursement to help its clients develop their claims payment accuracy.
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.